Review of the Application of Dual Drug Delivery Nanotheranostic Agents in the Diagnosis and Treatment of Liver Cancer
Molecules · 2023
DOI: 10.3390/molecules28207004 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules, 2023. Verfasst von Qinghe Han und 3 weiteren Autor:innen. Beteiligte Einrichtung: Radiology Department, The Second Affiliated Hospital of Jilin University, Changchun 130062, China. Hauptthemen laut MEDLINE: Metal Nanoparticles, Nanoparticles, Liver Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jilin Province Science and Technology Department, Bethune Plan Project.
Abstract (Originalsprache)
Liver cancer has high incidence and mortality rates and its treatment generally requires the use of a combination treatment strategy. Therefore, the early detection and diagnosis of liver cancer is crucial to achieving the best treatment effect. In addition, it is imperative to explore multimodal combination therapy for liver cancer treatment and the synergistic effect of two liver cancer treatment drugs while preventing drug resistance and drug side effects to maximize the achievable therapeutic effect. Gold nanoparticles are used widely in applications related to optical imaging, CT imaging, MRI imaging, biomarkers, targeted drug therapy, etc., and serve as an advanced platform for integrated application in the nano-diagnosis and treatment of diseases. Dual-drug-delivery nano-diagnostic and therapeutic agents have drawn great interest in current times. Therefore, the present report aims to review the effectiveness of dual-drug-delivery nano-diagnostic and therapeutic agents in the field of anti-tumor therapy from the particular perspective of liver cancer diagnosis and treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Radiology Department, The Second Affiliated Hospital of Jilin University, Changchun 130062, China.
- Department of Radiotherapy, The Second Affiliated Hospital of Jilin University, Changchun 130062, China.
ORCID-Profile: Lianze Du
Förderung
- Jilin Province Science and Technology Department
- Bethune Plan Project
Zitieren
APA
Han, Q., Du, L., Zhu, L., & Yu, D. (2023). Review of the Application of Dual Drug Delivery Nanotheranostic Agents in the Diagnosis and Treatment of Liver Cancer. Molecules. https://doi.org/10.3390/molecules28207004
Vancouver
Han Q, Du L, Zhu L, Yu D. Review of the Application of Dual Drug Delivery Nanotheranostic Agents in the Diagnosis and Treatment of Liver Cancer. Molecules. 2023. doi:10.3390/molecules28207004
BibTeX
@article{Han2023,
author = {Han, Qinghe and Du, Lianze and Zhu, Lili and Yu, Duo},
title = {Review of the Application of Dual Drug Delivery Nanotheranostic Agents in the Diagnosis and Treatment of Liver Cancer},
journal = {Molecules},
year = {2023},
doi = {10.3390/molecules28207004}
}
EUVIMED